ozempic novo nordisk - Search News

Novo Nordisk’s stock is rallying

Novo Nordisk shares are rallying as Hims & Hers’ stock falters. An Ozempic alternative won’t be available for long.

Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer.

Wall Street Journal · 17h

Novo Nordisk Stock Rallies on Weight-Loss Retreat by Hims & Hers

Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to Novo Nordisk's Wegovy and Ozempic weight-loss drugs. Hims stock stood about 17% lower at under $42.

The Motley Fool on MSN · 12d

Why Novo Nordisk Stock Keeps Going Down

Novo Nordisk ( NVO -1.22%) stock is in a funk. Shares of the GLP-1 diet drug manufacturer have been sliding all week long, beginning with a 3% decline on Monday from last Friday's close, and falling another 2.6% through 10:10 a.m. ET on Thursday.

FDA, Ozempic

NBC New York · 4d

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.

CBS News on MSN · 3d

FDA declares end to Wegovy and Ozempic shortage

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

AOL · 3d

FDA announces end to Wegovy and Ozempic drug shortages, but it could mean higher prices

The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is over.

4don MSN

Novo’s Ozempic Shortage Is Declared Over, Hitting Copycats

Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...

Costs could rise for people using copycats of Ozempic, Wegovy

People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide ...

ConsumerAffairs10h

Hims & Hers withdraws from Wegovy, Ozempic market

Hims & Hers is stopping its sales of an alternative to blockbuster weight-loss drugs Wegovy and Ozempic. That follows the U.S ...

The Washington Post5d

FDA says Ozempic shortage is over, chilling boom in off-brand versions

Novo Nordisk’s Ozempic and Lilly’s Mounjaro treat Type 2 diabetes, while Wegovy and Zepbound are anti-obesity medications. The FDA has long warned that compounded medications, which it doesn ...

10hon MSN

England subsidises drugs like Ozempic for weight loss. Could Australia follow?

If Australia followed England’s lead and listed drugs such as Wegovy on the PBS for weight loss, this could bring the cost ...

15hon MSN

In China you can get Ozempic and Wegovy within the hour for just $100 a month

Delivery apps are allowing Chinese citizens to get their hands on the popular weight-loss and diabetes drugs at the touch of ...

Newser on MSN1d

FDA Change on Ozempic to Shake Up the Market

The shortage of Ozempic and Wegovy has been declared over by the Food and Drug Administration, a change that suggests higher ...

Channel 4 News12h

Should we be worried about deaths linked to weight loss jabs including Ozempic?

Medical treatments, including jabs used for weight loss, are monitored in part using the Medicines and Healthcare products ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results